FindTrial
Sign In

Etiopathological study of Vikrita Kleda with special reference to Laboratory Parameters

Etiopathological study of Vikrita Kleda with special reference to Laboratory Parameters - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072391
Enrollment
100
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

None listed

Sponsors

Dr ABDUL MUHITH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing to participate in the study. Subjects having the clinical features mentioned for Kleda will be included.

Exclusion criteria

Exclusion criteria: Not willing to participate in the study. Pregnant and lactating women. Subjects with immunocompromised states like HIV, Tuberculosis, Hepatitis B & C etc.Subjects with malignancy.

Design outcomes

Primary

MeasureTime frame
For the establishment of a clear correlation between Vikrita Kleda and specific diseases, enabling a deeper understanding of the underlying pathological processes.Timepoint: One and half years—

Secondary

MeasureTime frame
Development of a framework for diagnosing and managing diseases related to Vikrita Kleda, based on Ayurvedic principles and practices.Timepoint: 1 and half years—

Countries

India

Contacts

Public ContactPROF DR ANUP BAISHYA

Government Ayurvedic College and Hospital, Guwahati 14

baishya.anup.815@gmail.com8638211711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026